Today: 29 April 2026
Vertex (VERX) stock slides after Thursday pop as insiders buy and management heads to investor conferences
27 February 2026
1 min read

Vertex (VERX) stock slides after Thursday pop as insiders buy and management heads to investor conferences

New York, February 27, 2026, 09:41 (EST) — Regular session

  • Shares of Vertex dropped about 4% early Friday, pulling back after Thursday’s rally.
  • A trust linked to the CEO snapped up 60,000 shares this week, according to a regulatory filing.
  • According to the company, investor “fireside chats” are set for next week at events hosted by Citizens JMP and Morgan Stanley.

Vertex, Inc. dropped about 4% to $14.24 early Friday, lagging as tech stocks broadly pulled back. The stock traded in a tight band, hitting lows of $14.15 and topping out at $14.53, after ending Thursday at $14.84.

The move stands out—Vertex is once again reacting straight to tape moves. Insiders stepped in to buy, while executives hit the road to talk up the story with investors. Since that rough patch in February, the stock’s yet to find its footing. For traders, that combination usually means spreads stay wide and momentum keeps running hot.

Vertex builds software for handling indirect tax—think sales tax and VAT—for business clients. These companies often get a spotlight at investor conferences, where executives can talk about how demand is shaping up. Sometimes they stick to existing guidance, but every so often, they’ll toss in a few extra details.

Chief Executive Chris Young and CFO John Schwab will take part in “fireside chats” at a pair of conferences—Citizens JMP Technology on March 3, then Morgan Stanley TMT the following day, the company said. Vertex intends to broadcast both sessions live, with replays set to be posted on its investor relations page. GlobeNewswire

This week brought fresh activity: a living trust linked to Young snapped up 60,000 shares of Vertex Class A on Feb. 23, according to a Form 4. The weighted average on the buy? $12.1799. Prices ranged between $11.9832 and $12.2862.

Insider activity followed familiar patterns. Director David DeStefano reported the conversion of 109,233 restricted stock units into shares, a filing shows. Of those, 51,983 shares were sold at $13.26 apiece to satisfy tax obligations on the vesting event. RSUs like these are standard equity awards and typically convert once vesting conditions are met.

Vertex shot up 10.83% to close at $14.84 on Thursday, a sharp move from Wednesday’s $13.39, according to StockAnalysis. Shares didn’t hold those gains on Friday, slipping during the session.

It all comes back to Vertex’s guidance from February. In the Feb. 11 earnings report, Young flagged “double-digit revenue growth” on tap for 2025, saying European e-invoicing mandates would provide a near-term lift. Schwab referenced a 2026 outlook with sustained double-digit increases, and noted the company bought back about $10 million worth of shares in Q4, part of its $150 million repurchase program.

Even with conferences and a handful of insider buys, the main figures haven’t budged. If Thursday’s jump looks, to investors, like a positioning move and not a real change, the stock might keep dropping. That risk only gets sharper if softness sticks around in application software and liquidity keeps fading.

Stock Market Today

  • Tuya (TUYA) Stock Analysis: Fair Pricing Amid Recent Pullback and Strong Long-Term Gains
    April 29, 2026, 12:05 PM EDT. Tuya (NYSE:TUYA) shares closed at $2.28, down 3.0% in one day and 6.2% over seven days, contrasting with a 3-year total shareholder return of 28.7%. The company reported $321.8 million in annual revenue and $57.9 million net income. Trading at a price-to-earnings (P/E) ratio of 24.1x, Tuya's valuation is slightly above its fair value estimate of 23.5x and peers' average of 21.7x, but below the broader U.S. Software industry average of 30.4x. This reflects investor confidence in its profitability and growth prospects, with earnings expected to grow nearly 10% annually. Risks include dependence on Chinese market demand and relatively rich valuation compared to peers. The stock trades just 0.9% below its intrinsic value according to discounted cash flow (DCF) estimates, suggesting near fair pricing.

Latest article

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

29 April 2026
Chicago, April 29, 2026, 11:04 CDT GE HealthCare Technologies Inc. cut its 2026 profit outlook on Wednesday, sending its shares down about 13%, after rising chip, oil and freight costs, tariffs and a supplier issue squeezed margins at the medical equipment maker. The move matters now because demand was not the main problem. GE HealthCare still reported revenue growth, positive orders and a $21.8 billion backlog, but investors focused on how much of that demand can turn into profit while input costs stay high. The company lowered its full-year adjusted earnings forecast to $4.80 to $5.00 a share from $4.95
Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

29 April 2026
Cognizant forecast second-quarter revenue below analyst estimates and announced Project Leap, a cost-cutting program focused on workforce reductions. Shares fell $1.67 to $53.45. The company reported first-quarter revenue of $5.41 billion, up 5.8%, and agreed to acquire AI infrastructure firm Astreya for about $600 million.
GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL
Previous Story

GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL

Tesla stock edges lower as robotaxi permit snag, insider sale plan keep TSLA under the microscope
Next Story

Tesla stock edges lower as robotaxi permit snag, insider sale plan keep TSLA under the microscope

Go toTop